Bone Biologics Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BBLG research report →
Companywww.bonebiologics.com
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1.
- CEO
- Jeffrey Frelick
- IPO
- 2021
- Employees
- 2
- HQ
- Burlington, MA, US
Price Chart
Valuation
- Market Cap
- $2.21M
- P/E
- -0.77
- P/S
- 0.00
- P/B
- 0.47
- EV/EBITDA
- 0.80
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -50.45%
- ROIC
- -64.27%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-3,108,991 · 24.39%
- EPS
- $-2.65 · 45.13%
- Op Income
- $-3,234,942
- FCF YoY
- 34.76%
Performance & Tape
- 52W High
- $6.75
- 52W Low
- $1.05
- 50D MA
- $1.26
- 200D MA
- $1.74
- Beta
- 0.53
- Avg Volume
- 13.99K
Get TickerSpark's AI analysis on BBLG
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 8, 26 | Walsh Deina H | other | 8,335 |
| Jan 8, 26 | Frelick Jeff | other | 16,668 |
| Jun 4, 25 | Meikle Phillip Terry II | other | 62,894 |
| Jun 4, 25 | Angle Siddhesh Rajendra | other | 62,894 |
| Jun 4, 25 | Stroever Bruce | other | 62,894 |
| Jun 4, 25 | Gagnon Robert E. | other | 62,894 |
| Jan 15, 25 | Frelick Jeff | other | 54,110 |
| Jan 15, 25 | Walsh Deina H | other | 27,055 |
| Oct 16, 24 | Meikle Phillip Terry II | other | 28,185 |
| Oct 16, 24 | Meikle Phillip Terry II | other | 9 |
Our BBLG Coverage
We haven't published any research on BBLG yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BBLG Report →